Carrots’ carotenoids contribute to eye health

Data from a population survey was analyzed by a Harvard University led team. The study tracked more than 100,000 patients aged fifty years and older over a period of 25 years. Researchers found that patients who consumed the highest levels of lutein and zeaxanthin were 40 percent less likely to develop the advanced form of […]

Groundbreaking procedure may be the cure for macular degeneration

A 60-year-old woman in London was the recipient of the first embryonic stem cell operation and she is the first of ten patients who are taking part in a trial. The woman suffered from the wet form of macular degeneration and was classified as legally blind. Surgeons at Moorfields Eye Hospital in London took a […]

Guess who’s more at risk for recurrent wet macular degeneration?

A retrospective cohort study which reviewed 343 Asian eyes with subfoveal neovascular AMD, which was treated with three monthly anti-VEGF injections of ranibizumab found a link between age and gender and the likelihood of recurrence of the condition. Older men were the patients who required re-treatement within twelve months of their initial treatment. At the […]

Your eyes are what you eat?

A study published in the American Journal of Ophthalmology presented a possible link between the stereotypical American diet and risk of developing macular degeneration. Researchers compared the Asian dietary pattern to the Western dietary pattern of those who participated in the Age-Related Eye Disease Study. Dietary intake was determined by data collected from a 90-item food […]

Does cost go into macular degeneration prescription decisions?

When it comes to treating the wet form of macular degeneration, there are two drugs that doctors typically consider and while the drugs are equally effective, the cost of each is dramatically different. Researchers decided to examine whether the cost difference between these two had significant bearing upon which drug a doctor prescribed. Ranibizumab was […]

Formula derived from computer analysis forecasts AMD

Researchers at Standford University School of Medicine have developed a formula based on analyzing computer imaging data that is gathered in eye doctors’ offices to determine which patients are most likely to develop the advanced form of macular degeneration. The research was documented in Investigative Ophthamology & Visual Sciences. The formula is based upon computer […]

Eylea on fast track for diabetic retinopathy treatment

Regeneron Pharmaceuticals announced that the FDA has classified Eylea as a breakthrough therapy to treat diabetic retinopathy in patients who already have diabetic macular edema.This classification expedites the process for Eylea to be FDA approved. Currently, Eylea has FDA approval for treatment of wet age-related macular degeneration, macular edema associated with central retinal vein occlusion […]

Reticular pseudodrusen found to be a risk factor for wet AMD

Researchers at the University of Melbourne have found a link between reticular pseudodrusen (RPD) and an increased risk of developing the wet form of macular degeneration. The study involved 200 patients with choroidal neovascularisation (CNV) secondary to age-related macular degeneration in one eye but with no signs of wet AMD in the other eye. The […]

UK Teaching hospitals using new wet AMD treatment

Some wet AMD patients in the United Kingdom are now receiving a new, non-invasive treatment for their disease. The new treatment known as Oraya Therapy™ is being used by eye specialists at the Sheffield’s Royal Hallamshire Hospital. This new therapy is painless and delivers highly targeted, low-energy X-rays to the eye. The amount of radiation […]

Hepatic Lipase Gene may reduce risk of Macular Degeneration

Researchers reviewed data from 10 case-control studies that included advanced AMD  (choroidal neovascularization or geographic atrophy)  patients that had undergone genotyping. They were looking for a relationship between the LIPC variant and advanced AMD. The results were published in the online JAMA Ophthalmology on July 10. What this review revealed is that the risk of […]